3 ·Filed Apr 29, 2026
Form 3 — initial insider ownership statement
Actionable Insight • Neutral
Routine CFO onboarding filing with zero ownership disclosed. No trading signal. Monitor future Form 4 filings for insider buying or selling activity.
Final — all horizons settled through T+60d
SKYE ▼ -27.08% at T+60d
NEUTRAL call ✗ call lost -27.08% · α vs SPY -31.19% · entry $0.8940 → $0.6519
T+1d
-1.68%
call -1.68% · α -2.70%
$0.8790
settled 5mo ago
T+5d
-4.81%
call -4.81% · α -7.92%
$0.8510
settled 5mo ago
T+20d
-4.92%
call -4.92% · α -10.97%
$0.8500
settled 4mo ago
T+60d
-27.08%
call -27.08% · α -31.19%
$0.6519
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
John P. Sharp filed a Form 3 initial statement of beneficial ownership, reporting no securities owned, in connection with his appointment as Chief Financial Officer of Skye Bioscience, Inc. This is a routine administrative filing for a new officer with no financial data or trading activity disclosed.
Key Facts
- John P. Sharp appointed Chief Financial Officer of Skye Bioscience, Inc.
- Form 3 filed on 2026-04-28, reporting period 2026-03-31
- Reporting person owns 0 shares of common stock
- No derivative securities reported
Financial Impact
No financial impact — zero securities reported
Risk Factors
- No material risks identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001628280-26-028062 |
| Document: 0001628280-26-028062-index-headers.html | 0001628280-26-028062 |
| Document: 0001628280-26-028062-index.html | 0001628280-26-028062 |
| Document: 0001628280-26-028062.txt | 0001628280-26-028062 |
9 reports for SKYE
100% Hit rate best @ T+5▲ +44.17%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 20, 2026 6w ago | DEFA14A | $0.2809 $1.77 | ▲ +528.34% | ▲ +528.34% | $1.68 (+498.08%) |
Aug 14, 2026 7w ago | 8-K | $0.5015 $1.99 | ▲ +296.81% | ▲ +298.80% | $1.68 (+235.00%) |
Aug 14, 2026 7w ago | Press Release | $0.5015 $1.99 | ▼ −296.81% | ▼ −298.80% | $1.68 (−235.00%) |
May 15, 2026 20w ago | 8-K | $0.7780 $0.7184 | ▲ +7.66% | ▲ +9.24% | $1.68 (−115.94%) |
May 12, 2026 20w ago | Press Release | $0.8140 $0.7800 | ▲ +4.18% | ▲ +2.45% | $1.68 (−106.39%) |
Apr 29, 2026 22w ago | 3 | $0.8940 $0.8500 | ▼ −4.92% | ▼ −10.97% | $1.68 (+87.92%) |
Apr 16, 2026 24w ago | DEFA14A | $0.7500 $0.8200 | ▲ +9.33% | ▲ +3.52% | $1.68 (+124.00%) |
Apr 2, 2026 26w ago | Press Release | $0.6980 $0.8790 | ▲ +25.93% | ▲ +16.05% | $1.68 (+140.69%) |
Mar 10, 2026 29w ago | Press Release | $0.7210 $0.7260 | ▲ +0.69% | ▲ +0.17% | $1.68 (+133.01%) |
Showing 9 of 9
US Market Status
Market Closed — Opens Mon (65h 2m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access